Metastatic ovarian cancer
Clinical trials for Metastatic ovarian cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic ovarian cancer trials appear
Sign up with your email to follow new studies for Metastatic ovarian cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a smart drug missile take down a tough ovarian cancer?
Disease control Recruiting nowThis phase 2 trial is testing whether a targeted antibody-drug conjugate called sacituzumab tirumotecan, given alone or together with the immunotherapy pembrolizumab, can shrink tumors in people with ovarian clear cell carcinoma that has returned after prior immunotherapy. The st…
Matched conditions: METASTATIC OVARIAN CANCER
Phase 2 • Sponsor: Tufts Medical Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could your own tumor cells fight cancer? new trial tests immune cell therapy
Disease control Recruiting nowThis phase 2 trial tests whether specially selected immune cells taken from a patient's own tumor, grown in large numbers in the lab, and given back along with the drug pembrolizumab (Keytruda) can shrink tumors in people with metastatic colorectal, pancreatic, ovarian, breast, o…
Matched conditions: METASTATIC OVARIAN CANCER
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new drug tackle Hard-to-Treat gynecologic cancers?
Disease control Recruiting nowThis early-stage trial is testing an investigational drug called ARR-002 in adults with advanced or metastatic ovarian or endometrial cancer, including cases that have stopped responding to platinum-based chemotherapy. The main goals are to assess the drug's safety, tolerability,…
Matched conditions: METASTATIC OVARIAN CANCER
Phase 1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug ERX-315 enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage trial tests the safety of a new drug called ERX-315 in 36 adults with advanced solid tumors (like breast, ovarian, or pancreatic cancer) that have stopped responding to standard treatments. Participants receive the drug intravenously twice a week at increasing do…
Matched conditions: METASTATIC OVARIAN CANCER
Phase 1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC